Stocks drifted to the downside Tuesday as investors took a breather from a three-day rally amid high oil prices and ongoing turmoil in Libya.
The Dow Jones Industrial Average was down more than 10 points after rallying in the previous session. The blue-chip index had risen 3.6 percent over the previous three sessions, after falling 4.3 percent from its Feb. 18, 2011 high.
Among Dow components, Bank of America [BAC 13.91
-0.14 (-1%)
] and Caterpillar [CAT 106.41
-1.18 (-1.1%)
] fell, while Verizon [VZ 37.00
0.54 (+1.48%)
] and Boeing [BA 72.08
0.88 (+1.24%)
] gained.
The S&P 500 and the Nasdaq were also slightly lower. The CBOE Volatility Index, widely considered the best gauge of fear in the market, fell near 20.
Among the S&P 500’s key sectors, telecom and utilities gained, while industrials and consumer discretionary fell.
Investors appeared to be taking a pause Tuesday after three consecutive sessions of strong gains reversed a good portion of the losses sustained in the wake of the multiple disasters in Japan.
“I would say the impressive part of that is we handled a lot of very negative news, very unexpected, uncertain news, and saw a relatively minor pullback as a consequence,” said Marc Pado, U.S. market strategist and technical analyst at Cantor Fitzgerald.
One reason the market didn’t continue to plunge is earnings season is just around the corner, and stocks tend to get a lift before earnings are released, Pado said.
“I think as the market moves to digest all the negative news, what’s new is that there’s positive news around the corner that people have been anticipating,” he said.
Pado also pointed to strength in companies such as Caterpillar [CAT 106.41
-1.18 (-1.1%)
] or Boeing [BA 72.08
0.88 (+1.24%)
] , which are benefiting from capital equipment expenditures triggered by the tax depreciation allowance. His expectation is the market could stall this week, with the S&P 500 trading around 1,300, but that the bull market run will be recharged, and the broad market index could reach 1,385 in the next couple of months.
Oil prices moved higher amid unrest in Yemen and after a third night of air strikes on the Libyan capital Tripoli. London Brent crude [LCOCV1 115.13
0.17 (+0.15%)] rose above $115 a barrel, while U.S. light sweet crude [CLCV1 103.55
1.22 (+1.19%)] rose above $104 a barrel.
“Oil isn’t going down anytime soon,” Rachel Ziemba, senior research analyst for Roubini Global Economics (RGE), told CNBC. “The question is, when it spikes to $150, do people expect it to stay there? What if it averages $115-120 a barrel?.”
RGE predicts that at that point the global economy would be spending almost 6 percent of GDP on oil. “In the past that has always preceded recession. We’re already starting to see a slowing global growth,” she said.
In Japan, the president of the Tokyo stock exchange told CNBC said the bourse was not considering shortening trading hours to deal with the electricity shortage Japan faces following the devastating earthquake. Shares in Japan rose 4 percent on Tuesday.
Sony [SNE 32.23
-0.19 (-0.59%)
] said it would have to cut or stop production at five more plants in Japan because of supply chain disruptions.
And Toyota shares [TM 82.83
-0.92 (-1.1%)
] slipped after the Japanese automaker decided to extend the vehicle-production halt which started on March 14 at all plants in Japan through March 26.
The CTIA wireless conference kicked off in Orlando. The future of Sprint [S 4.5385
0.176 (+4.03%)
] , which plunged 14 percent on Monday after AT&T’s [T 28.14
-0.12 (-0.42%)
] acquisition of T-Mobile, will be a key topic. Many investors had expected the logical partner for T-Mobile to be Sprint. Meanwhile, Raymond James upgraded Sprint to “strong buy” from “outperform,” saying the drop in the stock as a result of AT&T/T-Mobile merger announcement was “overdone.”
The CEO of Verizon Wireless [VZ 37.00
0.54 (+1.48%)
] , meanwhile, said he had no interest in buying Sprint.
Research in Motion’s [RIMM 62.29
0.12 (+0.19%)
] tablet, the Blackberry Playbook, will go on sale April 19 for $499.
Also on the tech front, Apple [AAPL 340.16
0.86 (+0.25%)
] sued Amazon.com [AMZN 162.40
-2.125 (-1.29%)
] over the online retailer’s use of “App Store”, saying Amazon.com improperly used the trademark to attract software developers.
Netflix [NFLX 219.97
7.13 (+3.35%)
] gained after Credit Suisse raised the movie rental firm to “outperform” from “neutral.” Shares of rival Tivo [TIVO 8.64
-0.01 (-0.12%)
] rose after news hedge fund Citadel Advisors accumulated a 5.3 percent stake in the company, according to a 13G filing.
Bank of New York Mellon [BNY 13.946
-0.005 (-0.04%)
] traded flat even after news the bank would raise its dividend to 13 cents a share from 9 cents. The firm also said it would buy back up to $1.3 billion in stock this year.
Last week, the Fed told banks the results of stress tests on their capital positions, and indicated whether they could go ahead with dividend increases and stock buybacks, among other decisions affecting capital ratios.
Banks were trading mixed across the border, as most had traded higher in anticipation of dividend increases. JPMorgan [JPM 45.51
-0.12 (-0.26%)
] and Wells Fargo [WFC 31.59
-0.29 (-0.91%)
] traded lower.
On the earnings front, Walgreen [WAG 39.13
-2.84 (-6.77%)
] fell even after the drugstore chain posted sales above expectations, while Dollar General [DG 30.77
0.39 (+1.28%)
] rose after the retailer’s earnings doubled.
After the close, software maker Adobe Systems [ADBE 32.53
0.19 (+0.59%)
] and credit card company Discover [DFS 22.4008
-0.2392 (-1.06%)
] are scheduled to report earnings results.
Shares of Tiffany [TIF 59.77
-0.45 (-0.75%)
] declined slightly after the luxury jeweler cut its first quarter outlook because it had to close stores in Japan after the earthquake and tsunami. The company reported a 29 percent jump in fourth quarter income on strong demand both domestically and overseas.
And Hot Topic shares [HOTT 5.28
0.125 (+2.42%)
] gained after the teen apparel retailer said CEO Betsy McLaughlin resigned.
On the health care front, Bristol-Myers Squibb [BMY 26.36
0.36 (+1.38%)
] climbed the biopharmaceutical firm received good news from a trial for its melanoma drug Ipilimumab.
Meanwhile, regulatory pressure prompted Sanofi-Aventis [SNY 33.95
-0.05 (-0.15%)
] and Merck [MRK 32.57
0.18 (+0.56%)
] to abandon plans for a joint animal health powerhouse with $5 billion in sales.
Goldman Sachs raised its price targets on health insurers Aetna [AET 35.32
-0.25 (-0.7%)
] , Cigna [CI 42.21
0.25 (+0.6%)
] , Humana [HUM 64.94
-0.30 (-0.46%)
] and UnitedHealth [UNH 42.68
-0.51 (-1.18%)
] . However, shares were trading mixed.
On the economic front, the Federal Housing Finance Authority said home prices fell 0.3 percent in January from December, and the Richmond Fed Index came in at 20 for March, down from 25 in February.